250 related articles for article (PubMed ID: 25845489)
1. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.
Baumann Kreuziger LM; Kim B; Wieselthaler GM
J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489
[TBL] [Abstract][Full Text] [Related]
2. What is the optimal anticoagulation in patients with a left ventricular assist device?
Rossi M; Serraino GF; Jiritano F; Renzulli A
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapies in children on durable Ventricular Assist Devices: A literature review.
Huang JY; Monagle P; Massicotte MP; VanderPluym CJ
Thromb Res; 2018 Dec; 172():194-203. PubMed ID: 29501323
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy for the CardioWest temporary total artificial heart.
Ensor CR; Cahoon WD; Crouch MA; Katlaps GJ; Hess ML; Cooke RH; Gunnerson KJ; Kasirajan V
Tex Heart Inst J; 2010; 37(2):149-58. PubMed ID: 20401285
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic therapy for durable left ventricular assist devices: protocol for a living systematic review with indirect comparison/network meta-analysis.
Derzi SH; Dewidar O; Sabri H; Tran D; Wells GA
BMJ Open; 2024 Jun; 14(6):e080110. PubMed ID: 38925683
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Left Ventricular Assist Device Thrombosis: Single-Center Experience.
Beyazpınar DS; Ersoy Ö; Gültekin B; Aliyev A; Avsever M; Akay HT; Özkan M; Sezgin A; Aşlamacı S
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):165-167. PubMed ID: 29528019
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
Mehra MR; Netuka I; Uriel N; Katz JN; Pagani FD; Jorde UP; Gustafsson F; Connors JM; Ivak P; Cowger J; Ransom J; Bansal A; Takeda K; Agarwal R; Byku M; Givertz MM; Bitar A; Hall S; Zimpfer D; Vega JD; Kanwar MK; Saeed O; Goldstein DJ; Cogswell R; Sheikh FH; Danter M; Pya Y; Phancao A; Henderson J; Crandall DL; Sundareswaran K; Soltesz E; Estep JD;
JAMA; 2023 Dec; 330(22):2171-2181. PubMed ID: 37950897
[TBL] [Abstract][Full Text] [Related]
11. The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
Santos CD; Matos NL; Asleh R; Dawit S; Rabinstein AA; O'Carroll CB; Li Z; Freeman WD
Neurocrit Care; 2020 Jun; 32(3):822-827. PubMed ID: 31531758
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Whitlock RP; Sun JC; Fremes SE; Rubens FD; Teoh KH
Chest; 2012 Feb; 141(2 Suppl):e576S-e600S. PubMed ID: 22315272
[TBL] [Abstract][Full Text] [Related]
13. Platelet inhibition with ticagrelor for left ventricular assist device thrombosis.
Oliveira GH; Al-Kindi SG; ElAmm C; Qattan MY; Deo S; Medalion B; Benatti RD; Osman MN; Ginwalla M; Park SJ; Simon DI
Circ Heart Fail; 2015 May; 8(3):649-51. PubMed ID: 25991808
[No Abstract] [Full Text] [Related]
14. Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: a single-center experience.
Fiore M; James C; Mouton C; Calderon J; Barandon L; Ouattara A; Picard F
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3119-25.e1. PubMed ID: 25212058
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy management of adult and pediatric cardiac surgery patients.
Baumann Kreuziger L; Karkouti K; Tweddell J; Massicotte MP
J Thromb Haemost; 2018 Nov; 16(11):2133-2146. PubMed ID: 30153372
[TBL] [Abstract][Full Text] [Related]
16. Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices.
Baumann Kreuziger LM
J Thromb Thrombolysis; 2015 Apr; 39(3):337-44. PubMed ID: 25549823
[TBL] [Abstract][Full Text] [Related]
17. Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis.
Susen S; Rauch A; Van Belle E; Vincentelli A; Lenting PJ
J Thromb Haemost; 2015 Oct; 13(10):1757-67. PubMed ID: 26302994
[TBL] [Abstract][Full Text] [Related]
18. HeartWare left ventricular assist device thrombosis in aspirin non-responder.
Dalén M; Sartipy U; Corbascio M; Lund LH; Grinnemo KH
Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):203-4. PubMed ID: 24585795
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents and anticoagulants for hypertension.
Shantsila E; Kozieł-Siołkowska M; Lip GY
Cochrane Database Syst Rev; 2022 Jul; 7():CD003186. PubMed ID: 35900898
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
